Feeds:
Posts
Comments

Posts Tagged ‘Gelnique’

Abbott and J&J to duke it out in court over a patent dispute on new rheumatoid arthritis drug.

Amylin eliminating 200 sales positionsDrugmaker Amylin Pharmaceuticals Inc. said Monday it will eliminate about 200 jobs, or more than a third of its sales force, as it combines its primary care and specialty drug sales units.Amylin partners with Eli Lilly & Co. to sell the diabetes drug Byetta, and is also developing a once-per-week version through that alliance. Amylin said the reorganization of its sales force will strengthen the partnership.

Gelnique works for OAB Applying a gel containing the anti-spasmodic agent oxybutynin to the skin is safe and effective for women with overactive bladder, according to a study reported here at the annual meeting of the American Urological Association.

——

Subscribe to the Impactiviti blog via e-mail

Subscribe to the Impactiviti blog via RSS

Connect with Steve Woodruff

Read Full Post »

Astellas makes a big to acquire CV Therapeutics. Japan’s Astellas Pharma is offering a billion dollars in cash for CV Therapeutics. The bid comes in at $16 a share, a whopping 41 percent premium over yesterday’s close.

Abilify as an add-on therapy for depression – not everyone is convinced.

Watson‘s topical Overactive Bladder gel (Gelnique) gets FDA approval.

PLUS – Amylin hurting. Abbott‘s Vicodin CR delay means 200 layoffs. And Feds say, “Enough with the off-label promotion already!

—––

Subscribe to the Impactiviti blog via e-mail

Subscribe to the Impactiviti blog via RSS

Impactiviti is a pharma consultancy focused on helping pharma/biotech/medical devices companies identify optimal vendors for training/marketing needs. This “matchmaking” service is provided free to clients.

Reblog this post [with Zemanta]

Read Full Post »